Parents' experience of a child with a large birthmark
Part of Genetic & congenital, Mental health, Skin clinical trials.
This study explores how parents feel and cope when their child has a large congenital melanocytic nevus, a type of birthmark. You would take part in a one-on-one interview to share your experience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are the parent of a child under 18 who has a large congenital melanocytic nevus.
- You can speak and understand French.
- You are willing to talk in a recorded interview.
- You are not under legal guardianship or curatorship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain birthmarks (nevi) change over time and might turn into melanoma. By studying tissue samples, researchers hope to better understand this process.
This study tests whether a topical drug called SADBE, applied to a congenital mole (a birthmark), can help reduce the mole before surgery. It is an early-stage trial, so it will help us learn if the treatment is safe and works.
This trial uses a precision medicine approach for people with melanoma. It studies how volatile organic compounds (substances your body releases) might help guide treatment for stage II, III, or IV melanoma.
This study looks at how removing a large birthmark mole (a congenital melanocytic nevus) affects children’s quality of life and how much they feel stigmatized. It may help doctors understand what to expect and how to support kids before and after surgery.
This study follows babies and toddlers with medium to large birthmarks to understand how they change over time and plan the best care. It will help doctors give better advice to families.
This study talks with people who have NF1 (and caregivers of children with NF1) about how visible tumors affect them. The goal is to create questionnaires that measure these concerns, which could lead to better support and treatments.
Hear when a new Congenital Melanocytic Nevus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.